2
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T38907 | FTISADTSK | ||
FTISADTSK is an endogenous stable signature peptide derived from Trastuzumab, which can be accurately assessed using selected reaction monitoring (SRM). | |||
T38023 | FTISADTSK acetate | ||
FTISADTSK acetate is a stable endogenous signature peptide sourced from Trastuzumab, which can be monitored using selected reaction monitoring (SRM)[1]. |